Pharmaceutical Radiation Radiation Oncology 
AuntMinnie
JULY 12, 2024
Beyder, along with Vikas Prasad, MD, PhD, and BJH/WU Radiation Oncology all played an integral role in launching the SNMMI radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, Barnes-Jewish Hospital, and Siteman Cancer Center last year. Involve radiation safety early in your therapy center development.
Imaging Technology
JULY 27, 2023
The company is a pre-clinical stage biotech company focused on advancing the field of radiation oncology through accelerator-based Boron Neutron Capture Therapy (BNCT), based in Santa Monica, CA. Hill joined TAE Life Sciences as Chief Operating Officer (COO) in October 2018.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
JANUARY 8, 2024
Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.
AuntMinnie
JULY 11, 2023
Pharmaceutical industry companies were involved in payments to diagnostic radiolog.
Imaging Technology
APRIL 2, 2024
announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. There is also special focus on radiation therapy and Theranostics. Oncotarget. 2017 Jun 8;8(37):62742-62758.
AuntMinnie
JANUARY 24, 2024
TerraPower Isotopes has shipped its first samples of Actinium-225 (Ac-225) to two pharmaceutical companies to develop targeted cancer treatments in drug trials. Ac-225 is an alpha-emitting radionuclide that can be attached to a ligand that binds to cancer cells.
AuntMinnie
JUNE 3, 2024
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology. led by Harshad Kulkarni, MD, as principal investigator.
Expert insights. Personalized for you.
105 
Let's personalize your content